<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We analyzed the expression of the Thy-1 antigen (CD90) in CD34+ <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> using two-color flow cytometry </plain></SENT>
<SENT sid="1" pm="."><plain>Leukemic cells were obtained from the bone marrow (BM) and/or the peripheral blood (PB) of 57 patients: 37 with <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) including nine with <z:e sem="disease" ids="C0280449" disease_type="Neoplastic Process" abbrv="">secondary AML</z:e> following <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), and 20 with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) including three with <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> in <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> (<z:mp ids='MP_0005481'>CML</z:mp>-BC) of the lymphoid type </plain></SENT>
<SENT sid="2" pm="."><plain>Among these patients, one (3.6%) with de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, two (22.2%) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, three (17.6%) with de novo ALL, and two (66.7%) with <z:mp ids='MP_0005481'>CML</z:mp>-BC coexpressed CD34 and Thy-1 (CD34+ Thy-1+) on more than 20% of the mononuclear cells within 'lymph' plus 'blast' window </plain></SENT>
<SENT sid="3" pm="."><plain>Thy-1 was rarely expressed in de novo <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> especially in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Interestingly, in 1 patient with <z:mp ids='MP_0005481'>CML</z:mp>-BC, the leukemic cells in BM were divided into two subpopulations (CD34+ Thy-1low and CD34+ Thy-1high), whereas most of the CD34+ leukemic cells in PB were Thy-1high </plain></SENT>
<SENT sid="5" pm="."><plain>However, the mechanism for the mobilization of CD34+ Thy-1high leukemic cells into the PB is unknown </plain></SENT>
</text></document>